
Faculty @OHSUKnight l @YaleHemOnc Fellow l @ASH_hematology Trainee Council 2022-2024 l MD-UCV 🇻🇪 - views are my own
Portland, OR
Joined May 2021
- Tweets163
- Following252
- Followers231
- Likes829
Jessica M. Stempel retweeted
Dr. Nikolai Podoltsev presents @eaonc E1910 Ph III trial of the addition of Blinatumomab to consolidation therapy for older, newly diagnosed patients with BCR::ABL1 negative B-Lineage Acute Lymphoblastic Leukemia #ALL #ASH24 with Selina Loger, MD @PennCancer & @MRLitzow ash.confex.com/ash/2024/webp…
Jessica M. Stempel retweeted
Celebrating Dr. Jennifer Afranie-Sakyi, @YaleHemOnc, and her presentation of implementation rates of the @ASH_hematology cerebrovascular guideline screening for silent cerebral infarct and cognition in #sicklecelldisease #SCD at #ASH24! @cececalhounMD @YaleHematology @SmilowCancer
ash.confex.com/ash/2024/webp…
Jessica M. Stempel retweeted
So proud of you Nicole!
Honored to have been invited back to @SHAhamden to talk to this brilliant group of SHA girls about my journey through medical training. Thanks for having me! 🩺🗒️
Jessica M. Stempel retweeted
Had an amazing time at #ASH2024 meeting friends, attending great talks and finally getting the great news of passing my Hematology ABIM while enjoying this great view of SD.
Jessica M. Stempel retweeted
Dr Luca Lanino @YaleCancer @HumanitasMilano presenting an excellent project that developed a molecular classification & a new, independently validated, risk stratification tool that outperformed all the other available for #CMML in collaboration with @genomed4all @ic_MDS
Jessica M. Stempel retweeted
.@KunalPotnis reveals that at the current pricing, eltrombopag plus traditional immunosuppressive therapy is unlikely to be a cost-effective treatment for adults with severe aplastic anemia in the US. #ASH24 @GeorgeGoshuaMD @YaleHematology @SmilowCancer ash.confex.com/ash/2024/webp…
Excited to share our work! Thank you @Dr_AmerZeidan @Dr_RoryShallis for your mentorship and support!
Dr @JMStempel fantastically presented our investigator-initiated randomized phase 2 trial of aza-ven +/- Pembro in older #AMLsm #ASH24 which was unfortunately -ve but showed importance of using ELN2024 for risk stratification & feasibility of central MRD in primary endpoint #IMG
Jessica M. Stempel retweeted
An overview of treatment patterns & outcomes of CAR-T & Bispecific T-Cell Engager BiTE therapies in Relapsed/Refractory #MultipleMyeloma from @SmilowCancer @YaleCancer, presented by Poy Theprungsirikul, MD @YaleHemOnc #ASH24 @NataliaNeparid1 @YaleHematology ash.confex.com/ash/2024/webp…
Incredible work by @Alhajahjeh_Abd !!
Thank you @Dr_AmerZeidan for all the great support you give me I will make sure to be at the intended level.
1
2
288
Jessica M. Stempel retweeted
.@JMStempel & Dr. Nikolai Podoltsev share research demonstrating that Calcineurin Inhibitor + Eltrombopag is effective in reducing transfusion requirements for patients w acquired #AplasticAnemia. #ASH24 @SmilowCancer @YaleHemOnc @YaleHematology @OncoAlert
ash.confex.com/ash/2024/webp…
Jessica M. Stempel retweeted
It was a pleasure to participate in this rapid mentoring sessions! Always happy to contribute even with encouraging words in the journey of the next generation of hematologists ❤️
@KellyMezaMD @MaryCushmanMD
@GomezDLeonMD @JMStempel
#mentoring #ASHEducation #ASH24 @ClaudSVillaCeli
Jessica M. Stempel retweeted
Wondering why so many clinical trials end prematurely? Our latest research digs into this critical issue. This work would not have been possible without such an excellent team @Alhajahjeh_Abd @JMStempel @Dr_AmerZeidan @MaxStahlMD @BewersdorfJan...@TradIMYale @YaleMedPSTP
Jessica M. Stempel retweeted
🚨Calling all Hematology & Oncology doctors! Please take this 5-minute survey on grit and resilience ➡ ycci.co1.qualtrics.com/jfe/f…
Jessica M. Stempel retweeted
It might take us a second to coordinate getting a group picture, but it's because we just like each other. And we certainly love our first year fellows class! It was a joy learning about each of you at the Heme-Onc Fellows Welcome Party. You already make our family richer. 💙
Jessica M. Stempel retweeted
Grateful for the opportunity to join this phenomenal group of current & future leaders of #cancer research at the @ASCO @AACR #MCCR #VailWorkshop. Huge thanks🙏🏼to all the organizers & faculty esp patient advocates. Shoutout to the best PDG-12!! #mssm @Myeloma_Society @theMMRF
Jessica M. Stempel retweeted
Check out our research paper on the clinical and molecular features of extramedullary AML @LeukemiaJnl. Grateful for the amazing co-authors @ClevelandClinic. @CarmeloGurnari @Bahaj_MD @olisaogbue
@CarrawayHetty @VisconteValeria
doi.org/10.1038/s41375-024-0…














































